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Abstract
Background: Cell-permeant Cre DNA site-specific recombinases provide an easily controlled
means to regulate gene structure and function in living cells. Since recombination provides a stable
and unambiguous record of protein uptake, the enzyme may also be used for quantitative studies
of cis- and trans-acting factors that influence the delivery of proteins into cells.
Results: In the present study, 11 recombinant fusion proteins were analyzed to characterize
sequences and conditions that affect protein uptake and/or activity and to develop more active cell-
permeant enzymes. We report that the native enzyme has a low, but intrinsic ability to enter cells.
The most active Cre proteins tested contained either an N-terminal 6xHis tag and a nuclear
localization sequence from SV40 large T antigen (HNC) or the HIV Tat transduction sequence and
a C-terminal 6xHis tag (TCH6). The NLS and 6xHis elements separately enhanced the delivery of
the HNC protein into cells; moreover, transduction sequences from fibroblast growth factor 4,
HIV Tat or consisting of the (KFF)3K sequence were not required for efficient protein transduction
and adversely affected enzyme solubility. Transduction of the HNC protein required 10 to 15 min
for half-maximum uptake, was greatly decreased at 4°C and was inhibited by serum. Efficient
recombination was observed in all cell types tested (a T-cell line, NIH3T3, Cos7, murine ES cells,
and primary splenocytes), and did not require localization of the enzyme to the nucleus.
Conclusions: The effects of different sequences on the delivery and/or activity of Cre in cultured
cells could not be predicted in advance. Consequently, the process of developing more active cell-
permeant recombinases was largely empirical. The HNC protein, with an excellent combination of
activity, solubility and yield, will enhance the use of cell-permeant Cre proteins to regulate gene
structure and function in living cells.
Background
The Cre recombinase from bacteriophage P1 has been
widely used to induce DNA sequence-specific recombina-
tion in mammalian cells [1]. The enzyme, which catalyzes
recombination between 34 nucleotide LoxP sequences
during P1 genome replication, has been used in a variety
of genetic applications to regulate gene structure and func-
tion. These include conditional mutagenesis, gene
replacement, chromosome engineering, and regulated
gene expression [2-4]. However, the use of site-specific
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recombination in genetic studies is frequently hampered
by difficulties expressing the recombinase in cells at the
desired time and place [5]. Moreover, the use of Cre
expression vectors is constrained by the fact that pro-
longed exposure to the enzyme can be lethal to cells
[4,6,7].
To address these problems, we [8] and others [9-12] have
developed membrane-permeable Cre recombinase pro-
teins that are capable of entering cells by a process of pro-
tein transduction. Protein transduction exploits
properties of specific protein sequences [termed protein
transduction domains (PTDs)] that enhance the delivery
of macromolecules – including peptides, proteins, and
DNA fragments – into living cells [13-15]. Cell-permeant
Cre proteins provide an effective means to regulate gene
structure and function in living cells, and Cre-mediated
recombination provides a potentially useful reporter sys-
tem with which to study the process of protein transduc-
tion itself. In particular, recombination provides a stable
and quantitative record of protein uptake that circum-
vents problems of distinguishing between internalized
and cell-associated proteins [16].
In our previous report, recombinant fusion proteins bear-
ing the 12 amino acid membrane translocation sequence
(MTS) from fibroblast growth factor 4 (FGF-4) were used
to deliver enzymatically active Cre proteins directly into
mammalian cells. Of the four recombinant proteins
tested, an enzyme containing an N-terminal 6xHis affinity
tag, a nuclear localization sequence (NLS) from SV40
large T antigen, and the FGF-4 MTS (HNCM), displayed
the best combination of yield, solubility, nuclear localiza-
tion and enzymatic activity within cells. Recombination
was observed in greater than 70% of cells treated with 10
µM HNCM for 2 hours. Widespread recombination was
also observed in mice following intraperitoneal adminis-
tration of HNCM, indicating that a wide variety of termi-
nally differentiated cell types can internalize cell-
permeant Cre and are competent to undergo site-specific
recombination.
In the present study, eleven recombinant Cre proteins
were prepared in order to evaluate sequences affecting the
uptake and/or activity of the enzyme in cultured cells and
if possible to develop more active recombinases. Several
constructs were designed to compare the activities of dif-
ferent PTDs, including the FGF-4 MTS [17], sequences
from HIV TAT [18] and a (KFF)3K sequence that was pre-
viously used to deliver peptide nucleic acid (PNA) conju-
gates into cells [19]. Only the Tat sequence promoted the
delivery of active Cre into cells, while all three PTD
sequences adversely affected the solubility of recombinant
proteins containing polyhistidine tags. The contribution
of the SV40 large T antigen NLS [20] was also examined to
understand apparent differences in the behaviour of cell-
permeant Cre and proteins expressed following gene
transfer. Thus, the activity of cell-permeant Cre was
enhanced by the SV40 large T antigen NLS [8,10],
whereas, the native Cre protein appears to possesses a
functional NLS, whose activity was not augmented by the
T antigen NLS [21]. We report that polyhistidine tags
(6xHis) frequently used for protein affinity purification
[22] and the large T antigen NLS each separately enhance
cellular uptake of enzymatically active Cre, and we
describe the development of a cell-permeant Cre recombi-
nase with an excellent combination of activity, solubility
and ease of purification.
Results
Recombinant Cre fusion proteins
Eleven recombinant Cre proteins were prepared in order
to evaluate sequences affecting the uptake and/or activity
of cell-permeant enzymes (Figure 1A). Native Cre (Cre)
corresponds to the protein encoded by the P1 phage
genome [23]. HC and H6C have amino-terminal hexahis-
tidine tags consisting of MGSSHHHHHHSSLVPRGSH
and MHHHHHH, respectively, while CH6 is similar to
H6C except the His tag is on the C-terminus. His-NLS-Cre
(HNC) is similar to HC except a nuclear localization
sequence (PKKKRKV) from SV40 large T antigen [20] is
positioned between His and Cre. HT7N'C is similar to
HNC except the His tag contains 11 additional amino
acids (MASMTGGQQMG) from the pET28a(+) polylinker
and the arginine of the NLS sequence was converted to a
lysine. This change, which resulted from an altered PCR
primer, is unlikely to affect nuclear localization activity.
HNCM, described previously [8], contains a membrane
translocation sequence (MTS) from the leader sequence of
FGF-4 positioned at the C-terminus of HNC. Finally, four
different sequences, each reported to have protein trans-
duction activity [17,19,24], were placed on the amino ter-
minus of CH6. These consisted of the FGF-4 MTS (MCH6),
an SV40 large T antigen nuclear localization sequence
(NCH6), the HIV Tat sequence (TCH6), and a (KFF)3K
sequence (KCH6).
Cre proteins were expressed from pET28a(+) plasmids in
E. coli and, except for native Cre, were purified by Ni2+
affinity chromatography under non-denaturing condi-
tions [8]. The native enzyme was purified by a combina-
tion of hydroxyapatite column chromatography and
Sephacryl S-100 HR FPLC. All proteins were expressed at
high levels, with yields of purified proteins ranging from
5 to 41 mg/L of E. coli culture (Figure 1). All of the
enzymes except TCH6 and KCH6 could be dialyzed against
DMEM or RPMI media and stored at -20°C until use.
However, TCH6 precipitated under these conditions and
was dialyzed instead against PBS supplemented with 0.3
M NaCl (0.45 M total NaCl) and 8% glycerol. The pH ofBMC Biotechnology 2004, 4:25 http://www.biomedcentral.com/1472-6750/4/25
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Recombinant Cre fusion proteins Figure 1
Recombinant Cre fusion proteins. (A) Structures of recombinant Cre fusion proteins. Cre sequences from nucleotide 484 
to 1513 (GenBank X03453) were expressed unaltered or incorporated into fusion proteins containing one or more of the fol-
lowing elements: His (MGSSHHHHHHSSLVPRGSH); His6 (MHHHHHH or HHHHHH for N- and C-terminal sequences, 
respectively); NLS (PKKKRKV); NLS' (PKKKKKV); T7 (MASMTGGQQMG); MTS (AAVLLPVLLAP); TAT (YGRKKRRQRRR) 
and (KFF)3K (KFFKFFKFFK). The table on the right lists the name, size (number of amino acids), yield following purification 
from E. coli (mg/L), relative solubility, and in vitro specific activity (units per milligram of enzyme) of each fusion protein. (B). 
Analysis of purified Cre fusion proteins. Purified Cre fusion proteins were fractionated by SDS-PAGE and stained with 
Coomassie blue.BMC Biotechnology 2004, 4:25 http://www.biomedcentral.com/1472-6750/4/25
Page 4 of 13
(page number not for citation purposes)
the buffer (ranging from 7.5–8.5) had no obvious effect
on protein solubility. The KCH6 protein was insoluble
over a range of pH values and salt concentrations (up to
0.8 M), and the protein was not evaluated further. The
remaining proteins could be prepared at final concentra-
tions above 1 mg/ml except HNCM, which precipitated
out of solution at protein concentrations above 500 µg/
ml. The specific activities of the tagged fusion proteins
were similar, ranging from 4.3–8.5 × 104 U/mg protein,
corresponding to 47–92% of the activity of the native
enzyme (Figure 1).
Native Cre recombinase has protein transduction activity 
that is enhanced by polyhistidine and NLS sequences
The uptake and enzymatic activity of Cre proteins was
monitored in Tex.loxP.EG cells [8]. These cells contain a
single integrated retrovirus (Fig 2A) in which the expres-
sion of an enhanced green fluorescent protein (EGFP)
gene is prevented by a "stop cassette" consisting of multi-
ple polyadenylation sites positioned between two loxP
sites. Deletion of the stop cassette by Cre mediated-recom-
bination activates the expression of the EGFP reporter
gene. Cells were exposed to Cre, HC, HNC, HT7N'C,
HNCM, H6C, CH6, NCH6, and TCH6 for 2 hrs at concen-
trations ranging from 0 to 8 µM. The cells were then
washed extensively with PBS, were cultured for 24 hrs to
provide time for EGFP expression, and the percentage of
EGFP-expressing cells was determined by flow cytometry.
Recombination was also monitored by Southern blot
hybridization (Fig 2C), thus confirming that expression of
the EGFP reporter accurately reflected the extent of tem-
plate recombination.
As shown in Figure 2B, all of the proteins tested induced
recombination in a concentration-dependent manner.
The native enzyme had the lowest activity, inducing
recombination in up to 17% of the cells. Uptake and/or
activity was increased by polyhistidine tags positioned on
either the amino- (HC and H6C) or carboxy-terminal
(CH6) ends of the enzyme. HC, which contains the 6xHis
tag from pET28a(+), and H6C and CH6, which contain
simple 6xHis sequences, induced similar levels of recom-
bination, ranging between 45 and 60% of cells. Activity
was further increased by the addition of an SV40 large T
antigen nuclear localization signal (HNC, HT7N'C and
NCH). At low concentrations, TCH6 was the most active
protein tested, but higher levels of the protein were toxic
to cells, presumably because of the concentration of NaCl
required to maintain protein solubility during prepara-
tion of the enzyme. Finally, presence of the FGF-4 MTS
sequence proved inhibitory for recombination in cultured
cells. HNC, which lacks the MTS sequence, was approxi-
mately 8 times more active than HNCM as determined by
the concentration of enzyme required to induce recombi-
nation in 50% of the cells. Thus, while the FGF-4 MTS has
been used to transduce a variety of proteins and peptides
into mammalian cells, the sequence suppressed the activ-
ity of cell-permeant Cre. This confirms the results of a ear-
lier study, reported while this work was in progress [10].
Temperature-dependent protein transduction
Transduction of cargoes containing the FGF-4 MTS [17],
including the HNCM protein used in this study [25], is
greatly decreased at 4°C as compared to 37°C. By con-
trast, there have been conflicting reports with regard to the
transduction of proteins containing the Tat and Antenna-
pedia PTDs [26-33]. Cre fusion proteins with (HNCM)
and without (HNC, HT7N'C and HC) the FGF-4 MTS were
therefore tested for their ability to enter cells at 4°C (Fig
3A). Tex.loxP.EG cells were incubated with varying con-
centrations of the proteins for one hour at either 37°C or
4°C; were washed extensively and were cultured at 37°C
to allow time for EGFP expression. In each case, the
uptake of the enzyme was inhibited at 4°C, indicating
that the inhibitory effects of low temperature are not lim-
ited to cargoes containing the FGF-4 MTS. Low levels of
recombination observed in cells treated with higher con-
centrations probably results from cell-associated enzyme
that the washing steps fail to remove and that gains entry
when cells are later cultured at 37°C.
Serum and cell density effects on protein transduction
Serum has been reported to inhibit the transduction of
cargoes containing the FGF-4 MTS; whereas, transduction
of proteins containing the Tat and Antennapedia PTDs
appears to be unaffected by serum. The effects of serum on
protein transduction were assessed by treating TexloxP.EG
cells with either HC (5 µM) or HNC (2 µM) for 1 hour in
the presence of varying concentrations of either fetal
bovine serum (Figure 3B, FBS) or normal mouse serum
(Figure 3B, MS). Recombination induced by both proteins
was inhibited by up to 60% and 80% in media containing
10% FBS and MS, respectively. Serum appeared to inhibit
protein transduction specifically, since it had no discerna-
ble effect on either the stability or activity of the proteins
in vitro (data not shown). These results indicate that the
inhibition of protein transduction by serum is not limited
to cargoes containing the FGF-4 MTS.
To assess the effects of cell density on protein transduc-
tion, TexloxP.EG cells were seeded at different concentra-
tions in 2 cm2 culture dishes and were treated with HNC
(2 µM) for 1 hour (Figure 3C). Recombination efficiencies
increased by about 40% as the number of number of cells
was increased from 104 to 6 × 104 cells/cm2, and then
declined sharply at concentrations above 2 × 105 cells/
cm2. Tex.loxP.EG is a T-cell line and is non-adherent;
however, the cells settle to the bottom of the culture dish.
The optimum density for recombination was similar toBMC Biotechnology 2004, 4:25 http://www.biomedcentral.com/1472-6750/4/25
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Cre-mediated recombination in cultured cells Figure 2
Cre-mediated recombination in cultured cells. (A). Structure of the recombination substrate in Tex.loxP.EG cells. The 
pBABE.lox.stp.EGFP retrovirus contains multiple polyadenylation sequences (stop cassette) flanked by loxP sites such that Cre-
mediated recombination activates the expression of an enhanced green fluorescent protein (EGFP) reporter gene. (B). Dose-
response of Cre-mediated recombination. Tex.loxp.EG cells were treated for two hours with increasing concentrations of 
each soluble Cre recombinase; were washed twice with PBS; and after 24 hours in normal growth medium, the percentage of 
GFP expressing cells was determined by FACS analysis. For clarity, the results obtained using different fusion proteins are plot-
ted in two panels. The Upper Panel shows results for HNC (solid squares), HT7N'C (solid circles), HNCM (open squares), HC 
(open circles), and Cre (solid triangles). The Lower Panel plots the results for NCH6 (solid squares), H6C (solid circles), and 
CH6 (solid triangles). (C). Southern blot analysis of Cre-mediated recombination. Tex.loxp.EG cells were treated with 0.5, 1.0, 
2.0, and 4.0 µM of HNC, HNCM and Cre proteins as described above, except after 24 hours DNA was extracted, digested 
with EcoR1 and analyzed by Southern blot analysis. Cre-mediated recombination results in the conversion of the loxP-contain-
ing fragment (upper band, U) to the recombination product (lower band, R).
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Temperature, serum and cell density effects on Cre-mediated recombination Figure 3
Temperature, serum and cell density effects on Cre-mediated recombination. (A) Transduction of cell-permeant 
Cre is inhibited at 4°C. Tex.loxp.EG cells were treated for 2 hours with increasing concentrations of the indicated enzymes at 
4 or 37°C and the cells were processed and analyzed for Cre-mediated recombination as described in Figure 1. (B) Effect of 
serum on Cre-mediated recombination. Tex.loxp.EGFP cells were treated for 2 hours with 2 µM HNC or with 5 µM HC in 
the presence of increasing concentrations of fetal bovine serum (FBS) or normal mouse serum (MS) and analyzed for Cre-
mediated recombination as described in Figure 1. The extent of recombination (percent GFP positive cells) was normalized to 
cells treated in the absence of serum. (B) Effect of cell density on Cre-mediated recombination. Increasing concentrations of 
Tex.loxp.EGFP cells were treated for 2 hours with 2 µM HNC and were analyzed for Cre-mediated recombination as 
described in Figure 1.
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the number of cells (.75 × 104 cells/cm2) required to cover
the culture dish.
Uptake and localization of cell-permeant Cre proteins
The kinetics of cell-permeant Cre uptake in cultured cells
was monitored by examining cells for recombination after
exposure to cell-permeant Cre for different lengths of time
(Figure 4). Cells were treated with HC (5 µM), HNC (3
µM) and HNCM (10 µM) for 5 to 120 mins, were washed
extensively and the extent of recombination was moni-
tored 24 hours later by flow cytometry. Thus, the assay
measures the time required for extracellular enzyme to
become committed to cell entry. The uptake of HC, HNC
and HNCM increased with time, reaching half-maximum
levels after 15–20 min. Recombination was induced in
cells following exposure to HNC and HNCM proteins for
less time than to HC, suggesting a direct role for the NLS
in promoting cell binding and/or entry. Note that the
observed differences (apparent within minutes after
exposing cells to Cre) cannot reflect potential differences
in nuclear trafficking since a delay in nuclear import of a
few minutes would not affect the extent of recombination
measured 24 hours later.
The uptake and localization of cell-permeant Cre in cul-
tured cells was also monitored in living cells by using pro-
teins labeled with the fluorescent dye, Alexa 488 (Figures
5 and 6). The uptake of tagged HC, HNC and HNCM
increased with the time as measured by flow cytometry
(Figure 5). Again, HNC and HNCM appeared to enter cells
more rapidly than HC, which lacks an NLS. Note that the
magnitude of the fluorescence is less important than the
rate of increase (slope) since the proteins were not
labelled to the same extent with Alexa 488.
The localization of Alexa 488-tagged HNC and HC pro-
teins was monitored in living cells by fluorescence micro-
scopy. The HNC protein was localized to the nuclei of
Cos7 cells, but was predominately cytoplasmic in NIH3T3
cells (Fig 6B). Cre protein was also localized to the nuclei
of Tex.loxP.EGcells (data not shown).
Recombination in different cell types
Several mammalian cell types were analyzed for their abil-
ity to undergo Cre-mediated recombination. Clones of
Cos7 and NIH3T3 cells containing a single
pBABE.lox.stp.EGFP provirus were treated with HNC for
two hour and analyzed by Southern blot hybridization
(Figure 7). Although the concentration of enzyme neces-
sary to achieve nearly complete recombination was
approximately 10 times higher in Cos7 cells than in
NIH3T3 cells (10 versus 1 µM, Figure 7), the recombina-
tion efficiency did not correlate with localization of the
enzyme to the nucleus (Figure 6). Extensive recombina-
tion was also observed in murine embryonic stem cells
containing a floxed IKK γ gene (Figure 7) and in primary
splenocytes explanted from ROSA26R mice (Figure 8).
Efficient recombination was therefore observed in all
mammalian cell types examined.
Discussion
Cell permeant Cre proteins have generated considerable
interest as genetic tools to regulate gene structure and
function in mammalian cells [5]. In addition, Cre medi-
ated recombination provides a quantitative reporter for
studies on the protein transduction process itself. In the
present study, 11 recombinant fusion proteins were ana-
lyzed to characterize sequences and conditions that affect
protein uptake and/or activity and to develop more active
cell-permeant enzymes. We report that the native enzyme
has a low, but intrinsic ability to enter cells. Uptake and
was enhanced by the addition of a 6xhistidine-tag on
either the amino or carboxyl terminal ends of the protein
and was enhanced further by the addition of a nuclear
localization sequence from SV40 large T antigen or the
transduction sequence from the HIV Tat protein. Finally,
the hydrophobic membrane translocation sequence
(MTS) from fibroblast growth factor 4 (FGF-4) had a net
deleterious effect on Cre-mediated recombination in cul-
tured cells.
We had hoped that the native or 6xHis-tagged enzymes
would lack transduction activity so that the effects of addi-
tional sequences on cell entry, nuclear transport and
recombination could be compared. However, we found
that the native Cre protein has an intrinsic ability to enter
cells, thus confirming observations by Will, et al. [11]. The
mechanism by which Cre gains entry into cells remains to
be determined. The enzyme may possess a protein trans-
duction domain analogous to those described for HIV Tat,
Kinetics of Cre binding and/or uptake Figure 4
Kinetics of Cre binding and/or uptake. Tex.loxp.EGFP 
cells were treated with HNC (3 µM), HNCM (10 µM) and 
HC (5 µM) for different lengths of time; were washed three 
times with PBS and were analyzed for Cre-mediated recom-
bination as described in Figure 1.
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Uptake of fluorescent Cre fusion proteins Figure 5
Uptake of fluorescent Cre fusion proteins. Tex.loxp.EG cells were treated for different lengths of time with the indicated 
Alexa 488-labeled Cre fusion proteins at 4 or 37°C and protein uptake was monitored by flow cytometry. (A) Kinetics of pro-
tein uptake. The mean fluorescence of cells treated with Alexa 488-labeled Cre fusion proteins, as calculated by the CellQuest 
software, increased with time and was inhibited at 4°C. (B) Representative FACS profiles of cells treated with the fluorescent 
HC protein. Cells were treated with Alexa 488-labeled HNCM at the indicated temperature for 0 (light gray, solid), 15 
(medium gray) and 120 min (black) and analyzed by flow cytometry. Profiles of cells treated for 30 and 60 min. have been omit-
ted for clarity.
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Intracellular localization of fluorescent Cre fusion proteins Figure 6
Intracellular localization of fluorescent Cre fusion proteins. Alexa 488-labeled HNC or HC proteins (1 µM) were 
incubated with Cos7 or NIH3T3 cells for 1.5 hr, and the living cells were directly visualized by fluorescence microscopy (green 
fluorescence, left panels). Cell nuclei counter stained with DAPI (blue fluorescence) are shown in the right panels and the 
merged images are shown in the middle panels.BMC Biotechnology 2004, 4:25 http://www.biomedcentral.com/1472-6750/4/25
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Antennapedia and a growing list of proteins that can enter
cells directly, without requiring specific receptor and
transporter systems [34]. The fact that Cre is a basic pro-
tein [23] is potentially significant considering that many
basic peptides are capable of entering cells [24,35-38].
The transduction activity of the native enzyme hinders
quantitative studies of sequences incorporated into
recombinant Cre proteins, since structural changes associ-
ated with each modification may have varying effects on
the intrinsic ability of Cre to enter cells. Even so, the 6xHis
sequence appeared to facilitate cell entry, since two differ-
ent 6xHis sequences enhanced Cre-mediated recombina-
tion while having little effect on the activity of the enzyme
in vitro. Moreover, 6xHis sequences were active when posi-
tioned on either the amino- or carboxyl-terminal ends of
the enzyme. L-histidine heptamers have been shown to
enter cells, although much less efficiently than arginine
homopolymers [37,38]. Positively charged histidine
sequences also bind cell surface heparin sulfate
proteoglycans [39,40], and thus may enhance uptake as
has been suggested for the HIV Tat transduction sequence
[41]. The transduction activity of the 6xHis sequences is
potentially significant given their widespread use as affin-
ity tags to purify recombinant fusion proteins [22].
We [8] and others [10] have shown that the activity of cell-
permeant Cre fusion proteins in cultured cells can be
enhanced by the addition of an SV40 large T antigen
nuclear localization sequence (NLS). The NLS has been
shown to enhance the activity of Cre expression vectors
[42], presumably by targeting the protein to the nucleus.
However, in the present study the NLS enhanced the
delivery of Cre fusion proteins into cultured cells as
assessed either by cell-based recombination or by uptake
of fluorescent Cre proteins. Moreover, nuclear localiza-
tion did not appear to contribute to cell type-specific dif-
ferences in the activity of the HNC protein. These results
are consistent with the observation that the T antigen NLS,
Cre-mediated recombination in different cell types Figure 7
Cre-mediated recombination in different cell types. 
Cos7 and NIH3T3 cells containing a single integrated copy of 
the pBABE.lox.stp.EGFP retrovirus and murine embryonic 
stem (ES) cells containing a floxed IKK γ gene were treated 
with 0, 0.5, 1.0, 2.0, 5.0, and 10 µM HNC (Cos7 and 
NIH3T3) or with 0, 0.25, 0.5, 1.0, 2.0, and 5.0 µM HNC (ES 
cells) for two hours. Cellular DNA was extracted, digested 
with EcoRI, and analyzed by Southern blot analysis. Cre-medi-
ated recombination results in the conversion of the loxP-
containing fragment (upper band, U) to the recombination 
product (lower band, R).
Cre-mediated recombination in primary splenocytes Figure 8
Cre-mediated recombination in primary splenocytes. 
Splenocytes from ROSA-26R mice were treated with 0 (thin 
black line), 1.0 (light grey line), 2.0 (dark grey line) and 5.0 
(thick black line) µM HNC recombinase in serum free media 
for 2 hours. The cells were washed, cultured for 24 hours, 
stained with a fluorescent β-galactosidase substrate 
(ImaGene green™, C12FDG) and analyzed by flow cytome-
try. Cre-mediated recombination, which activates the 
expression of a floxed lacZ gene, results in increased 
fluorescence.BMC Biotechnology 2004, 4:25 http://www.biomedcentral.com/1472-6750/4/25
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like a number of other basic sequences, has protein trans-
duction activity [24].
HNC, which consisted of a 6xHis tag and T antigen NLS
attached to the amino-terminus of the enzyme, was highly
active despite the absence of a canonical protein transduc-
tion sequence. The 6xHis tag and NLS sequences
separately contributed to the transduction of the enzyme,
which was 5–8 times more active in cultured cells than the
HisNLSCreMTS (HNCM) protein described in our earlier
study [8]. By virtue of their positive charge, these elements
share similarities with basic protein transduction
domains such as HIV Tat and Antennapedia. Early studies
suggested that the basic PTDs entered cells through an
energy-independent process that was relatively unaffected
by low (4°C) temperature [26-30]. However, later studies
suggest that the positively charged PTDs promote cell
uptake by endocytosis possibly by binding negatively
charged proteins on the cell surface [12,31-33,43,44].
Similarly, the uptake of Cre fusion proteins is consistent
with an endocytic mechanism. In particular, uptake (time
required for commitment to entry) was relatively rapid
(10 to 15 min for half maximum uptake), was greatly
decreased at 4°C, and was inhibited by up to 80% by
serum. The inhibition by serum appeared to involve cell
binding and/or entry specifically, since serum had no dis-
cernable effect on the stability or activity of Cre fusion
proteins in vitro (data not shown). Recombination was
markedly suppressed at higher cell densities, possibility
because binding sites in or on cells sequester the enzyme,
thus lowering the effective protein concentration. Alterna-
tively, cell density may suppress protein transduction by
reducing cell size and/or available surface area [25]. In
either event, similar observations have been reported for a
TatCre protein that lacks a 6xHis tag [9], illustrating the
need to control for cell density when comparing the
effects or cell-permeant proteins in different cell
populations.
Conclusions
The effects of different sequences on Cre uptake or activity
were difficult to predict in advance, and consequently, the
process of developing a more active cell-permeant recom-
binase was largely empirical. Proteins containing amino-
terminal Tat and (KFF)3K sequences (TCH6 and KCH6)
were poorly soluble when dialyzed against isotonic
media, and the FGF-4 MTS interfered with the activity of
the enzyme in cultured cells. Since Cre is probably not
unique in this regard, investigators seeking to develop
other cell-permeant proteins would be advised to test a
variety of sequences positioned at different places on the
protein. In the present case, the HNC protein possesses an
outstanding combination of activity, solubility and yield
that will enhance the use of cell-permeant Cre to regulate
gene structure and function in living cells.
Methods
Cre expression vectors
Native Cre and Cre fusion proteins were expressed in E.
coli from pET28a (+)-based plasmids (Novagen). A plas-
mid expressing native Cre (Cre) was constructed by using
the Cre #1 and Cre-stop-HindIII primers to amplify Cre
coding sequences from MBP-NLS-Cre-MTS [8] which were
cloned between the NcoI and HindIII sites of pET28a (+).
HC, His6C, HNC, and HT7C were similarly constructed by
PCR amplification, using primers Cre #2, Cre #3, Cre #4
and Cre #5, respectively, together with Cre-stop-HindIII
primer. The amplified DNA fragments were cloned into
NheI and HindIII sites of pET28a (+). CHis6, NCHis6,
MCHis6, TATCHis6, and (KFF)3KCHis6 were constructed
by using primers Cre #6, Cre #7, Cre #8, Cre #9 and Cre
#10, respectively, together with the Cre-XhoI primer, and
then cloned into the NcoI and XhoI sites of pET28b(+).
Cre #1: 
AGAGAGCCATGGGCTCCAATTTACTGACCGTACACCA
A
Cre #2: 
GTACATGCTAGCTCCAATTTACTGACCGTACACCAA
Cre#3: 
AGAGAGCCATGGGCCATCATCATCATCATCACAGCTC
CAATTTACTGACCGTACACCAA
Cre#4: 
GTACATGCTAGCCCAAGAAGAAGAGGAAGGTGCTCCA
ATTTACTGACCGTACACCAA
Cre#5: 
GTACATGAATTCTCCAATTTACTGACCGTACACCAA
Cre#6: 
AGAGAGCCATGGGCTCCAATTTACTGACCGTACACCA
A
Cre#7: 
AGAGAGCCATGGGCCCCAAGAAGAAGAGGAAGGTGT
CCAATTTACTGACCGTACACCAA
Cre#8: 
AGAGAGCCATGGGCGCAGCCGTTCTTCTCCCTGTTCTT
CTTGCCGCACCCTCCAATTTACTGACCGTACACCAA
Cre#9: 
AGAGAGCCATGGGCGGTCGCAAGAAACGTCGCCAAC
GTCGCCGTTCCAATTTACTGACCGTACACCAA
Cre #10: 
AGAGAGCCATGGGCAAATTCTTTAAGTTCTTTAAGTTCT
TTAAGTCCAATTTACTGACCGTACACCAABMC Biotechnology 2004, 4:25 http://www.biomedcentral.com/1472-6750/4/25
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Cre-stop-HindIII: 
GATACGAAGCTTCTACTAATCGCCATCTTCCAGCAGGC
GC
Cre – XhoI: 
AGAGAGCTCGAGATCGCCATCTTCCAGCAGGCGCACC
ATTGCCCCTGT
Protein purification
Polyhistidine-tagged Cre fusion proteins were expressed
in E. coli strain BL21 (DE3) and purified by Ni2+ affinity
chromatography as described previously [8]. Bacterial cul-
tures (2L) were grown to an A600 of 0.6–1.0, were induced
with 0.4 mM IPTG, and after harvesting the cells were
lysed in 40 ml 50 mM Tris (pH 8.0), 50 mM sodium phos-
phate and 300 mM NaCl. After affinity chromatography,
recombinant proteins were dialyzed against DMEM or
RPMI media, except TCH6 and KCH6, which precipitated
under these conditions. TCH6  was dialyzed instead
against PBS supplemented with 0.3 M NaCl (0.45 M NaCl
final) and 8% glycerol. The native recombinase was simi-
larly expressed; however, lysates were applied to a 50 ml
hydroxyapatite column and step-eluted with sodium
phosphate buffers (pH 8.0) of increasing concentration
(50, 100, 200, 300, and 500 µM). The peak fraction (200
µM) was dialyzed against PBS, was concentrated by cen-
trifugal ultra filtration to about 20 mg/ml and was frac-
tionated by Sephacryl S-100 HR gel filtration FPLC. Peak
fractions identified by SDS PAGE, were concentrated and
dialyzed against PRMI-1640 medium containing 1%
streptomycin/penicillin and 2% glycerol.
In vitro assays of Cre enzyme activity measured the release
of a circular plasmid inserted into a λ phage (Novagen,
Madison, WI) by transformation of E. coli [8]. One unit
(U) of enzyme produces 104 colonies (equivalent to 2 ×
106 circular molecules) in a 30 minute reaction containing
200 ng DNA substrate in 50 mM Tris HCl, pH 7.5, 33 mM
NaCl and 10 mM MgCl2 in a total volume of 15 µl. All Cre
proteins were stable for at least 6 months at -80°C with-
out significant loss of enzymatic activity.
Cell culture and protein transduction
Tex.loxp.EG, 3T3.loxp.EG and Cos7.loxp.EG cells were
derived from Tex (a murine thymoma line derived from
p53-deficient mice), NIH3T3 and Cos7 cells, respectively,
following infection with the pBABE.lox.stp.EGFP
retrovirus [8]. Cells were incubated with serum-free RPMI
1640 (Tex.loxp.EG) or DMEM (3T3.loxp.EG and
Cos7.loxp.EG) containing Cre fusion proteins for 2 hours,
then washed with PBS twice and cultured in normal
growth medium at 37°C incubator for 24 hours. Cre
mediated recombination, which induces the expression of
an enhanced green fluorescence protein (EGFP) in
Tex.loxp.EG cells, was measured by flow cytometry using
a FACSort instrument (Becton Dickinson). Alternatively,
recombination was monitored by Southern blot hybridi-
zation [8]. For experiments involving low temperature
protein transduction, the cells and all solutions were
maintained at 4°C until after washing with cold PBS, after
which the cells were returned to normal medium at 37°C.
Preparation of fluorescent HNC, HC, and HNCM proteins
Fluorescent HNC, HC, and HNCM proteins were pre-
pared by using the Alexa 488 protein labeling kit (Molec-
ular Probes, catalog number A-10235), according to the
manufacturer's instructions. The proteins were dialyzed
against PBS, were labeled at a concentration of 2 mg/ml
and purified by gel filtration through a Sephadex G50 col-
umn. Cells were treated with the fluorescent proteins at a
final concentration of 1 µM.
The localization of fluorescent Cre proteins was moni-
tored in living NIH3T3 and Cos7 cells by fluorescence
microscopy. The cells were cultured to 50–80% conflu-
ence in a slide chamber (NUNC), washed with PBS and
then incubated with fluorescent Cre proteins at a final
concentration of 1 µM for 1.5 hours. The cells were
washed three times with PBS, counterstained with 1 µg/ml
4',6-diamidino-2-phenylindole (DAPI) in PBS for 20
minutes, washed three times with PBS and mounted in
anti-fade fluorescence mounting medium. The stained
cells were photographed with an Olympus BX60 fluores-
cence microscope using green and blue filters.
Ex vivo recombination by HNC recombinase in primary 
cells
Splenocytes from ROSA-26R mice were cultured for one
day in RPMI 1640 medium containing 10% FBS and were
treated with HNC recombinase in serum free media for 2
hours. The cells were washed, cultured for 24 hours, and
stained with a fluorescent β-galactosidase substrate
(ImaGene green™, C12FDG) according to instructions pro-
vided by the manufacturer (Molecular Probes, Inc.)
Recombination, which activates the expression of a floxed
lacZ gene, was assessed by flow cytometry.
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